Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers

A Randomised, Double-blind 2 Way Crossover Trial to Investigate the Pharmacokinetics and Pharmacodynamics of Insulin X14 30/70 PreMix Compared to Human Insulin 30/70 PreMix in Healthy Volunteers

This trial is conducted in Europe. The aim of this trial is to investigate the pharmacokinetics and pharmacodynamics of insulin X14 30/70 PreMix compared to human insulin 30/70 PreMix in healthy volunteers.

Inclusion Criteria:

• Non-smokers
• BMI (body mass index) maximum 27 kg/m^2
• HbA1c (glycosylated haemoglobin A1c): 3.4-6.1%
• FBG (fasting blood glucose) maximum 6.0 mmol/L